Studies have shown that the SCGN-insulin interaction can stabilize insulin, enhance the hypoglycemic activity of insulin in vivo, and reduce hepatic steatosis and cholesterol metabolism disorders (51). Here, INS is linked to cholesterol metabolism disease.